Menu
Annual · values2025202420232022202120202019
Operating Cash Flow74.67 M USD38.80 M USD15.34 M USD-13.54 M USD22.99 M USD71.80 M USD40.71 M USD
Depreciation & Amortization47.01 M USD49.55 M USD57.37 M USD66.80 M USD34.88 M USD28.64 M USD30.32 M USD
Stock-Based Compensation12.67 M USD10.06 M USD2.72 M USD17.59 M USD19.84 M USD0 USD0 USD
Capital Expenditures2.56 M USD1.01 M USD7.36 M USD10.04 M USD7.37 M USD4.09 M USD2.34 M USD
Cash Flow from Investing-3.25 M USD22.96 M USD15.81 M USD-116.44 M USD-283.76 M USD-20.50 M USD-7.91 M USD
Cash Flow from Financing-62.14 M USD-54.58 M USD-26.65 M USD62.08 M USD273.37 M USD-29.57 M USD-10.95 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow72.11 M USD37.79 M USD7.98 M USD-23.58 M USD15.62 M USD67.71 M USD38.37 M USD

Bioventus Inc. operates as a medical device company focused on developing innovative medical solutions for musculoskeletal healing. Primarily, it seeks to enhance patients' quality of life through its products that aid in bone healing, pain management, and osteoarthritis care. The company's notable product categories include bone health products, joint pain products, and surgical solutions, which serve a critical role in orthopedics and sports medicine. Headquartered in Durham, North Carolina, Bioventus leverages advanced biological technologies to drive advancements in healthcare. By providing both surgical and non-surgical therapies, it plays a pivotal role in the market for enhancing patient recovery and addressing orthopedic ailments. Bioventus’ contributions are significant in clinical settings and for patients seeking less invasive alternatives to traditional treatments, marking it as a key player in the intersection of medical technology and patient care.